BPC 157 stabilizes GABA neurotransmitters, helping with withdrawals and tolerance of certain drugs and also decreasing anxiety
Gastrointestinal Research Given its origin from gastric juice proteins, BPC-157 has drawn considerable attention in GI research
First, rule out any underlying conditions such as kidney or liver disease, cancer, or other blood disorders, as these can raise B12 levels
Harvey Co
In a 2010 clinical trial, for example, subjects who received tesamorelin ended with an average 18% decrease in visceral fat compared to placebo.27 This fat-reducing quality is what makes tesamorelin an attractive non-GLP-1 peptide option
doi:10.1007/s12178-025-09966-7 Szcs GF, Vncsa S, Agcs G, et al